Entheon Biomedical Statistics

Total Valuation

CSE:ENBI has a market cap or net worth of CAD 1.66 million. The enterprise value is 1.53 million.

Market Cap	1.66M
Enterprise Value	1.53M

Important Dates

The next estimated earnings date is Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:ENBI has 13.86 million shares outstanding. The number of shares has increased by 30.96% in one year.

Current Share Class	n/a
Shares Outstanding	13.86M
Shares Change (YoY)	+30.96%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	2.02%
Owned by Institutions (%)	n/a
Float	13.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	11.44
P/TBV Ratio	11.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.80
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.52

Current Ratio	4.52
Quick Ratio	3.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -137.90% and return on invested capital (ROIC) is -90.19%.

Return on Equity (ROE)	-137.90%
Return on Assets (ROA)	-70.93%
Return on Invested Capital (ROIC)	-90.19%
Return on Capital Employed (ROCE)	-228.90%
Revenue Per Employee	n/a
Profits Per Employee	-317,923
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.83% in the last 52 weeks. The beta is 1.53, so CSE:ENBI's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	-47.83%
50-Day Moving Average	0.19
200-Day Moving Average	0.16
Relative Strength Index (RSI)	41.11
Average Volume (20 Days)	18,095

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-332,661
Pretax Income	-317,923
Net Income	-317,923
EBITDA	n/a
EBIT	-332,661
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

The company has 136,494 in cash and n/a in debt, giving a net cash position of 136,494 or 0.01 per share.

Cash & Cash Equivalents	136,494
Total Debt	n/a
Net Cash	136,494
Net Cash Per Share	0.01
Equity (Book Value)	145,328
Book Value Per Share	0.02
Working Capital	140,328

Full Balance Sheet

Cash Flow

Operating Cash Flow	-355,639
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:ENBI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.96%
Shareholder Yield	-30.96%
Earnings Yield	-19.12%
FCF Yield	n/a

Stock Splits

The last stock split was on March 1, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Mar 1, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a